Literature DB >> 11894849

Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease.

Fernanda U Fontella1, Edson Gassen, Vânia Pulrolnik, Clóvis M D Wannmacher, Adriane B Klein, Moacir Wajner, Carlos S Dutra-Filho.   

Abstract

In this study we investigated the in vitro effects of the metabolites accumulating in maple syrup urine disease on lipid peroxidation in brain of young rats. Chemiluminescence and thiobarbituric acid-reactive substances were measured in brain homogenates from 7- and 30-day-old rats in the presence of 10 mM of the branched-chain amino acids L-leucine, L-isoleucine, or L-valine; their keto acids L-2-ketoisocaproic acid, L-2-keto-3-methylvaleric acid, or L-2-ketoisovaleric acid; or the hydroxy derivatives L-2-hydroxyisocaproic acid, L-2-hydroxy-3-methylvaleric acid, or L-2-hydroxyisovaleric acid separately added to the incubation medium. We observed that all amino acids, keto acids, and hydroxy acids accumulating in this disease stimulate to a variable degree the in vitro parameters of lipid peroxidation tested in homogenates of rat brain. The results indicate a possible participation of oxidative stress in the neuropathology of maple syrup urine disease patients, especially during a crisis, when the metabolites are highly increased, and point to the use of antioxidant drugs as a possible adjuvant therapy in such situations to improve the neurological status of the patients and to prevent sequelae.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11894849     DOI: 10.1023/a:1014004414733

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  19 in total

1.  Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.

Authors:  R G Tavares; C E Santos; C I Tasca; M Wajner; D O Souza; C S Dutra-Filho
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

2.  Influence of alpha-ketoacids on the respiration of brain in vitro.

Authors:  R K HOWELL; M LEE
Journal:  Proc Soc Exp Biol Med       Date:  1963-07

3.  Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria.

Authors:  R E TASHIAN
Journal:  Metabolism       Date:  1961-05       Impact factor: 8.694

4.  Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.

Authors:  J M Land; J Mowbray; J B Clark
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

5.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Inhibition of mitochondrial pyruvate transport by phenylpyruvate and alpha-ketoisocaproate.

Authors:  A P Halestrap; M D Brand; R M Denton
Journal:  Biochim Biophys Acta       Date:  1974-10-10

Review 7.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: leucine infusion.

Authors:  Y Huang; H R Zielke; J T Tildon; C L Zielke; P J Baab
Journal:  Dev Neurosci       Date:  1996       Impact factor: 2.984

9.  Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle.

Authors:  B Gonzalez Flecha; S Llesuy; A Boveris
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

10.  Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease.

Authors:  T Taketomi; T Kunishita; A Hara; S Mizushima
Journal:  Jpn J Exp Med       Date:  1983-04
View more
  32 in total

1.  Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.

Authors:  Cláudia Funchal; Patrícia Fernanda Schuck; André Quincozes Dos Santos; Maria Caroline Jacques-Silva; Carmem Gottfried; Regina Pessoa-Pureur; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

2.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

3.  Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.

Authors:  Caroline Paula Mescka; Gilian Guerreiro; Bruna Donida; Desirèe Marchetti; Carlos Alberto Yasin Wayhs; Graziela Schimitt Ribas; Adriana Simon Coitinho; Moacir Wajner; Carlos Severo Dutra-Filho; Carmen Regla Vargas
Journal:  Metab Brain Dis       Date:  2015-05-24       Impact factor: 3.584

4.  Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.

Authors:  Giselli Scaini; Meline O S Morais; Camila B Furlanetto; Luiza W Kist; Talita C B Pereira; Patrícia F Schuck; Gustavo C Ferreira; Matheus A B Pasquali; Daniel P Gelain; José Cláudio F Moreira; Maurício R Bogo; Emilio L Streck
Journal:  Neurochem Res       Date:  2015-02-14       Impact factor: 3.996

5.  The intra-hippocampal leucine administration impairs memory consolidation and LTP generation in rats.

Authors:  Viviane Glaser; Valeria P Carlini; Laura Gabach; Marisa Ghersi; Susana Rubiales de Barioglio; Oscar A Ramirez; Mariela F Perez; Alexandra Latini
Journal:  Cell Mol Neurobiol       Date:  2010-06-26       Impact factor: 5.046

6.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 7.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

8.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

9.  Oxidative stress in plasma from maple syrup urine disease patients during treatment.

Authors:  Alethéa G Barschak; Angela Sitta; Marion Deon; Amanda T Barden; Carlos S Dutra-Filho; Moacir Wajner; Carmen R Vargas
Journal:  Metab Brain Dis       Date:  2007-11-17       Impact factor: 3.584

10.  Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid.

Authors:  Patrícia Fernanda Schuck; Estela Natacha Brandt Busanello; Alana Pimentel Moura; Anelise Miotti Tonin; Mateus Grings; Luciana Ritter; Carmen Regla Vargas; Gustavo da Costa Ferreira; Moacir Wajner
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.